Search for Novel Antibacterial Compounds and Targets

Area of Science:

• Natural Product Chemistry
• Microbiology
• Drug Discovery

Background:

• Rising prevalence of multidrug-resistant bacteria like MRSA, Pseudomonas aeruginosa, and VRE necessitates new antibacterial agents.
• Limited progress in developing novel antibiotics hinders effective treatment of resistant infections.
• Identification of novel compounds and molecular targets is crucial for combating antimicrobial resistance.

Purpose of the Study:

• To discover and characterize novel antibacterial compounds from natural sources.
• To investigate the mechanisms of action for identified antibacterial agents.
• To evaluate the potential of these compounds in treating drug-resistant bacterial infections.

Main Methods:

• Screening of natural products for antibacterial activity.
• Chemical isolation and structural elucidation of active compounds.
• Assays to determine mechanisms of action, including cell membrane integrity and enzyme inhibition (DNA topoisomerase IV).
• Evaluation of synergistic effects with existing antibiotics.

Main Results:

• Riccardin C (from liverwort) and 6,6 -dihydroxythiobinupharidine (from Senkotsu) demonstrated significant antibacterial activity, especially against Gram-positive bacteria.
• Riccardin C was found to induce cell membrane leakage.
• 6,6 -dihydroxythiobinupharidine inhibited DNA topoisomerase IV and showed synergistic effects with anti-MRSA drugs and vancomycin against VRE.

Conclusions:

• Riccardin C and 6,6 -dihydroxythiobinupharidine represent promising leads for developing new antibacterial drugs.
• The distinct mechanisms of action (membrane disruption and topoisomerase inhibition) offer potential for novel therapeutic strategies.
• Synergistic potential highlights the possibility of combination therapies to overcome existing resistance.